specific diseases
specific illnesses
pharmabiotic solutions
selection
MyBiotics
set of specific bacteria
antibiotic-associated disorders prevention Development of novel probiotic solutions
sufficient quantity of living probiotic
Colitis diseases
eco-innovative probiotic food supplement
ex
health problems
robust clinical results
bile salts
biologic barriers
pancreatic juice
gastric acid
lobbying activities
Obesity
Depression
unreached comfort
delivery technology
easy variation
EFSA
EMA
leverage
Crohn
targeted disease
Mycrobe TM
MycrobeTM